IGFBP‐rP1 is a potential therapeutic target in androgenic alopecia
    Research/Science 10/28/2024

    At a glance
    In this research discussion post, the primary subjects mentioned are the tone is 😀 positive with comparable to Minoxidil and 5-AR inhibitors results.

    Other terms

    IGFBP‐rP1 shows potential for treating androgenic alopecia by influencing hair cycle transitions. Increasing IGF-1 levels may have similar effects to Minoxidil and 5-AR inhibitors in reducing hair loss.
    View this post in the Community →

    Similar Community Posts Join

    5 / 6 results

    Related Research

    6 / 405 results